These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24533056)

  • 1. Evaluation of a cost effective in-house method for HIV-1 drug resistance genotyping using plasma samples.
    Chaturbhuj DN; Nirmalkar AP; Paranjape RS; Tripathy SP
    PLoS One; 2014; 9(2):e87441. PubMed ID: 24533056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and clinical evaluation of a low cost in-house HIV-1 drug resistance genotyping assay for Indian patients.
    Acharya A; Vaniawala S; Shah P; Misra RN; Wani M; Mukhopadhyaya PN
    PLoS One; 2014; 9(8):e105790. PubMed ID: 25157501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
    Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
    J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an in-house genotyping resistance test for HIV-1 drug resistance interpretation and genotyping.
    Chen JH; Wong KH; Chan K; Lam HY; Lee SS; Li P; Lee MP; Tsang DN; Zheng BJ; Yuen KY; Yam WC
    J Clin Virol; 2007 Jun; 39(2):125-31. PubMed ID: 17449318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Field evaluation of a broadly sensitive HIV-1 in-house genotyping assay for use with both plasma and dried blood spot specimens in a resource-limited country.
    Inzaule S; Yang C; Kasembeli A; Nafisa L; Okonji J; Oyaro B; Lando R; Mills LA; Laserson K; Thomas T; Nkengasong J; Zeh C
    J Clin Microbiol; 2013 Feb; 51(2):529-39. PubMed ID: 23224100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive in-house RT-PCR genotyping system for combined detection of plasma HIV-1 and assessment of drug resistance.
    Steegen K; Demecheleer E; De Cabooter N; Nges D; Temmerman M; Ndumbe P; Mandaliya K; Plum J; Verhofstede C
    J Virol Methods; 2006 May; 133(2):137-45. PubMed ID: 16375980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong.
    Chen JH; Wong KH; Li PC; Chan KK; Lee MP; To SW; Yam WC
    Hong Kong Med J; 2012 Feb; 18(1):20-4. PubMed ID: 22302906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of an in-house human immunodeficiency virus type 1 genotyping system for assessment of drug resistance in Cuba.
    Alemán Y; Vinken L; Kourí V; Pérez L; Álvarez A; Abrahantes Y; Fonseca C; Pérez J; Correa C; Soto Y; Schrooten Y; Vandamme AM; Van Laethem K
    PLoS One; 2015; 10(2):e0117176. PubMed ID: 25671421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CODEHOP-Mediated PCR Improves HIV-1 Genotyping and Detection of Variants by MinION Sequencing.
    Sarkhouh H; Chehadeh W
    Microbiol Spectr; 2021 Oct; 9(2):e0143221. PubMed ID: 34668751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for sequence-based analysis of diverse human immunodeficiency virus type 1 strains.
    Eshleman SH; Hackett J; Swanson P; Cunningham SP; Drews B; Brennan C; Devare SG; Zekeng L; Kaptué L; Marlowe N
    J Clin Microbiol; 2004 Jun; 42(6):2711-7. PubMed ID: 15184457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes.
    Wallis CL; Viana RV; Saravanan S; Silva de Jesus C; Zeh C; Halvas EK; Mellors JW
    J Virol Methods; 2017 Mar; 241():41-45. PubMed ID: 27993614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an in-house HIV-1 drug resistance genotypic testing for using dried blood spot specimens in China.
    Zhao H; Liao L; Xing H; Wang Z; Su B; Liu J; Wu J; Feng Y; He C; Ruan Y; Shao Y
    Curr HIV Res; 2015; 13(2):109-16. PubMed ID: 25495996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of in-house genotyping assay performance using dried blood spot specimens in the Global World Health Organization laboratory network.
    Parkin N; de Mendoza C; Schuurman R; Jennings C; Bremer J; Jordan MR; Bertagnolio S;
    Clin Infect Dis; 2012 May; 54 Suppl 4(Suppl 4):S273-9. PubMed ID: 22544187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotyping performance evaluation of commercially available HIV-1 drug resistance test.
    Rosemary A; Chika O; Jonathan O; Godwin I; Georgina O; Azuka O; Zaidat M; Philippe C; Oliver E; Oche A; David O; Jay S; Ibrahim D; Mukhtar A; Joshua D; Chunfu Y; Elliot R; Beth C; Phyllis K; Emmanuel I
    PLoS One; 2018; 13(6):e0198246. PubMed ID: 29953436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
    Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
    Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An affordable HIV-1 drug resistance monitoring method for resource limited settings.
    Manasa J; Danaviah S; Pillay S; Padayachee P; Mthiyane H; Mkhize C; Lessells RJ; Seebregts C; de Wit TF; Viljoen J; Katzenstein D; De Oliveira T
    J Vis Exp; 2014 Mar; (85):. PubMed ID: 24747156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1.
    Wallis CL; Papathanasopoulos MA; Lakhi S; Karita E; Kamali A; Kaleebu P; Sanders E; Anzala O; Bekker LG; Stevens G; de Wit TF; Stevens W
    J Virol Methods; 2010 Feb; 163(2):505-8. PubMed ID: 19917318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High concordance between HIV-1 drug resistance genotypes generated from plasma and dried blood spots in antiretroviral-experienced patients.
    Masciotra S; Garrido C; Youngpairoj AS; McNulty A; Zahonero N; Corral A; Heneine W; de Mendoza C; García-Lerma JG
    AIDS; 2007 Nov; 21(18):2503-11. PubMed ID: 18025887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Partially Multiplexed HIV Drug Resistance (HIVDR) Assay for Monitoring HIVDR Mutations of the Protease, Reverse-Transcriptase (PRRT), and Integrase (INT).
    DeVos J; McCarthy K; Sewe V; Akinyi G; Junghae M; Opollo V; Nouhin J; Shafer R; Zeh C; Ramos A; Alexander H; Chang J
    Microbiol Spectr; 2022 Jun; 10(3):e0177621. PubMed ID: 35510849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.